Study: Patented Magnesium Formula Said to Decrease Signs of Cognitive Decline

New findings in nutritional research reveal that magnesium deficiency in adults plays a more significant role in cognitive impairment and in Alzheimer’s disease than previously thought. A patented magnesium formula known as Magtein is said to prevent prevent synapse loss and reverse cognitive decline in mice with the disease.

“A recently concluded double blind, placebo-controlled human study, the ‘gold standard’ of science, demonstrates that dietary supplementation of Magtein, patented magnesium threonate, can significantly enhance human cognitive functions and decrease symptoms of cognitive impairments,” said the study’s author. Click here to read the full article.